AI assistant
Sending…
COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2021
Jan 20, 2021
32163_dirs_2021-01-20_50247504-f771-436e-bba5-765c2c3e8b87.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2021-01-15
Reporting Person: Dreyer Scott (EVP & Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-15 | Common Stock | S | 1322 | $22.89 | Disposed | 44395 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2020 and amended on December 7, 2020.
More from COLLEGIUM PHARMACEUTICAL, INC
Share Issue/Capital Change
2026
Jun 1
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 7
Report Publication Announcement
2026
May 7
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Board/Management Information
2026
Apr 7
Major Shareholding Notification
2026
Mar 26